INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2017

Infliximab combined with a plant-based diet induced high remission rates at 6 weeks in biologic-naïve patients with Crohn disease.

Biologic-naïve patients with Crohn disease received standard infliximab induction along with a lacto-ovo-semivegetarian diet during hospitalization. Two adults were withdrawn due to intestinal obstruction. Intention-to-treat and per-protocol remission rates at week 6 were 96% (44/46) and 100% (44/44), respectively. Mean CDAI score dropped from 314 on admission to 63 at week 6 (p < 0.0001), mean CRP decreased from 5.3 mg/dL to 0.2 mg/dL (p < 0.0001), and mucosal healing was achieved in 46% (19/41) of cases.

Study type
Prospective single-group trial
Who was studied
46 patients with Crohn disease naïve to biologics (26 newly diagnosed adults, 11 newly diagnosed children, 9 relapsing adults)
What was measured
Remission at week 6, CDAI score, CRP concentration, and mucosal healing

THE PAPER

Induction with Infliximab and a Plant-Based Diet as First-Line (IPF) Therapy for Crohn Disease: A Single-Group Trial.

Chiba M, Tsuji T, Nakane K, Tsuda S, Ishii H, Ohno H, Watanabe K, Ito M, Komatsu M, Sugawara T. Perm J, 2017.

PubMed 29035182 ↗DOI 10.1097/00004836-198808000-00011 ↗

Gut & microbiome

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.